Calliditas Therapeutics AB Sponsored ADR CALT shares rallied 16.1% in the last trading session to close at $19.01. This move can be attributable to notable volume with a higher number of shares ...

Calliditas Therapeutics (CALT) jumped 33% after the Swedish biotech company said its Nefecon drug candidate met its primary endpoint during phase 3 testing in patients with primary immunoglobulin ...